BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021;101:108217. [PMID: 34627083 DOI: 10.1016/j.intimp.2021.108217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Schultz IC, Bertoni APS, Wink MR. MSC-Exosomes Carrying miRNA - Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19? Stem Cell Rev Rep 2022. [PMID: 35794511 DOI: 10.1007/s12015-022-10409-w] [Reference Citation Analysis]
2 Huldani H, Margiana R, Ahmad F, Opulencia MJC, Ansari MJ, Bokov DO, Abdullaeva NN, Siahmansouri H. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. International Immunopharmacology 2022;107:108698. [DOI: 10.1016/j.intimp.2022.108698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Huldani H, Abdalkareem Jasim S, Olegovich Bokov D, Abdelbasset WK, Nader Shalaby M, Thangavelu L, Margiana R, Qasim MT. Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases. International Immunopharmacology 2022;106:108634. [DOI: 10.1016/j.intimp.2022.108634] [Reference Citation Analysis]
4 Fremed MA, Farooqi KM. Longitudinal Outcomes and Monitoring of Patients With Multisystem Inflammatory Syndrome in Children. Front Pediatr 2022;10:820229. [DOI: 10.3389/fped.2022.820229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
5 Mobasheri L, Hossein Nasirpour M, Masoumi E, Foolady Azarnaminy A, Jafari M, Esmaeili S. SARS-CoV-2 triggering autoimmune diseases. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155873] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
6 Jafari M, Kolahdooz H, Mahmoudi M, Azarnaminy AF, Mobasheri L, Esmaeili S. The impact of lymphoid memory cells in different ages of COVID-19 patients. Gene Reports 2022;26:101503. [DOI: 10.1016/j.genrep.2022.101503] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Huldani H, Abdalkareem Jasim S, Olegovich Bokov D, Kamal Abdelbasset W, Nader Shalaby M, Thangavelu L, Margiana R, Qasim MT. Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases. Int Immunopharmacol 2022;106:108634. [PMID: 35193053 DOI: 10.1016/j.intimp.2022.108634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
8 Staub HL, Staub LP. Síndrome inflamatória multissistêmica (SIMS) pós-COVID-19: Um conceito em evolução. Sci Med 2022;32:e42436. [DOI: 10.15448/1980-6108.2022.1.42436] [Reference Citation Analysis]